Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
SS18L1
REST API REST API
Homo sapiens
SS18L1 is differentially expressed in 236 experiments: 90 organism parts: cerebellum, bone marrow, ... (88 more);, 160 disease states: normal, acute myeloid leukemia, ... (158 more);, 71 cell types 334 cell lines 28 compound treatments and 68 other conditions.
Synonyms KIAA0693
Orthologs SS18L1 (Gallus gallus)   CREST_BOVIN (Bos taurus)   Ss18l1 (Mus musculus)   Ss18l1 (Rattus norvegicus)   ss18l1 (Xenopus laevis)   SS18L1 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term condensed nuclear chromosome, centromeric region, condensed chromosome kinetochore, nucleus, dendrite development, chromosome, chromatin modification, positive regulation of transcription, DNA-dependent
InterPro Term SSXT
UniProt Accession Q9BR54, O75177
Search EB-eye ENSG00000184402
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-AFMX-5, E-GEOD-6573, E-GEOD-1577, E-MTAB-24, ... (21 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-GEOD-19639, E-GEOD-18005, ... (35 experiments)

Factor Value U/D Experiments
WI38
2
E-MTAB-37, E-MTAB-62
A549
1
2
E-GEOD-6013, E-GEOD-3202
HT1080
2
E-MTAB-37, E-GEOD-20089
PC3
2
E-GEOD-5258, E-MEXP-2034
GRANTA-519
1
E-MTAB-62
TERV-ST110
1
E-MTAB-62
328 more value(s).


Cell type

studied in E-GEOD-22373, E-GEOD-21668, E-GEOD-3920, E-GEOD-360, E-GEOD-4219, ... (39 experiments)

Factor Value U/D Experiments
fibroblast
1
2
E-GEOD-3920, E-GEOD-3204, E-GEOD-26672
CD34 positive
1
E-GEOD-12662
SVGR2
1
E-GEOD-7819
B cell
2
1
E-GEOD-13987
iPSC derived from hASC using minicircle reprogramming vector
1
E-GEOD-20033
plasmablast
1
E-MEXP-2360
65 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-GEOD-15960, E-GEOD-2466, E-MEXP-2069, ... (46 experiments)

Factor Value U/D Experiments
prostate carcinoma
3
E-MTAB-62, E-MEXP-2034, E-MEXP-1327
acute lymphoblastic leukemia
2
E-GEOD-96, E-MTAB-62
neuroblastoma
2
E-MTAB-37, E-MTAB-62
acute promyelocytic leukemia
1
2
E-MTAB-62, E-GEOD-995, E-GEOD-1729
chondromyxoid fibroma
1
E-MTAB-62
Ewing sarcoma
1
E-MTAB-37
154 more value(s).


Compound treatment

studied in E-GEOD-5258, E-GEOD-15205, E-TABM-782, E-GEOD-5824, E-TABM-868, ... (18 experiments)

Factor Value U/D Experiments
none
3
5
E-GEOD-5824, E-MEXP-1958, E-GEOD-412, E-TABM-782, E-TABM-868, ... (8 experiments)
lipopolysaccharide
2
E-MEXP-1958, E-TABM-868
glucose
1
E-MEXP-941
glutamine
1
E-MEXP-941
sapphyrin PCI-2054
1
E-GEOD-6400
unknown
1
E-GEOD-7307
22 more value(s).


Age at diagnosis

studied in E-GEOD-3494, E-GEOD-4922

Factor Value U/D Experiments
86 years
1
E-GEOD-4922
86
1
E-GEOD-3494


Agent
studied in E-GEOD-19519

Biopsy tissue
studied in E-GEOD-5851

Biosource provider
studied in E-MTAB-37, E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-22097, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363, ... (6 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-4619, E-GEOD-20499, E-GEOD-21589, ... (7 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-20033, E-MEXP-2359

Disease staging
studied in E-GEOD-19743, E-MEXP-2280, E-TABM-147, E-GEOD-21138, E-GEOD-1751, ... (6 experiments)

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-MEXP-1482, E-GEOD-7578, E-GEOD-17385, ... (8 experiments)

Genotype
studied in E-GEOD-3494, E-GEOD-2466, E-GEOD-22593, E-TABM-868, E-GEOD-1153, ... (6 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-GEOD-7011, E-TABM-127, E-GEOD-20504, E-MEXP-1446, ... (9 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-GEOD-20194, E-GEOD-16716

Individual
studied in E-MTAB-197, E-TABM-325, E-GEOD-5764, E-GEOD-2466, E-GEOD-1926, ... (28 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-12108, E-GEOD-6927, E-GEOD-980, E-GEOD-17400, ... (6 experiments)

Injury
studied in E-GEOD-19743

Ki67 ihc
studied in E-GEOD-21653

Labeling
studied in E-LGCL-5

Material type
studied in E-MEXP-958

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-7540, E-GEOD-1801, E-AFMX-1, E-GEOD-426, E-TABM-84 ... (5 experiments)

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-7819, E-GEOD-19703, E-GEOD-21750, E-GEOD-1657

Population
studied in E-MTAB-197, E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-3254, E-GEOD-1880, E-GEOD-19445

Replicate
studied in E-GEOD-10896

RNAi
studied in E-MEXP-2115, E-MEXP-101, E-MEXP-1857

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-2466, E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11886

stimulus
studied in E-GEOD-22103

Strain or line
studied in E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-4922, E-GEOD-19188

Test result
studied in E-GEOD-1926, E-GEOD-2748

Treatment
studied in E-GEOD-19246, E-GEOD-19815, E-GEOD-15799

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-6532, E-GEOD-4922

Vehicle
studied in E-GEOD-5258

Processing time: 0.297 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM